Not applicableUnknownNCT04446741What this trial is testingMolecular Diagnostic Platform for AMLWho this might be right forAcute Myeloid Leukemia (AML) PETHEMA Foundation 2,000
Large-scale testing (Phase 3)Study completedNCT01751997What this trial is testingFamily-mismatched/Haploidentical Donors Versus Matched Unrelated DonorsWho this might be right forAcute Myeloid Leukemia Byung-Sik Cho 116
Not applicableStudy completedNCT01232855What this trial is testingBiomarkers in Tissue Samples From Patients With Acute Promyelocytic LeukemiaWho this might be right forLeukemia Children's Oncology Group 10
Testing effectiveness (Phase 2)Study completedNCT00004215What this trial is testingLeridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid LeukemiaWho this might be right forAnemiaLeukemiaNeutropenia+1 more Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00096148What this trial is testingIdarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaWho this might be right forAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+21 more National Cancer Institute (NCI) 120
Early research (Phase 1)Study completedNCT00890747What this trial is testingSunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAcute Undifferentiated Leukemia+82 more National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)WithdrawnNCT00030355What this trial is testingHomoharringtonine in Treating Patients With Refractory Acute Promyelocytic LeukemiaWho this might be right forLeukemia National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00003868What this trial is testingRadiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid LeukemiaWho this might be right forLeukemia Fred Hutchinson Cancer Center 40
Not applicableStudy completedNCT01385150What this trial is testingBiomarkers in Blood Samples From Patients With Acute Myeloid LeukemiaWho this might be right forLeukemia Eastern Cooperative Oncology Group 220
Testing effectiveness (Phase 2)Study completedNCT00004217What this trial is testingS9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid LeukemiaWho this might be right forLeukemia SWOG Cancer Research Network 55
Early research (Phase 1)Looking for participantsNCT02390752What this trial is testingPhase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...Who this might be right forNeurofibroma, PlexiformPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Promyelocytic, Acute+1 more National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)Looking for participantsNCT04195633What this trial is testingDonor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological MalignanciesWho this might be right forAcute LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+16 more Fred Hutchinson Cancer Center 60
Early research (Phase 1)Study completedNCT00093743What this trial is testingLow-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi AnemiaWho this might be right forAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+8 more Fred Hutchinson Cancer Center 2
Early research (Phase 1)Ended earlyNCT01550185What this trial is testingEltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid LeukemiaWho this might be right forAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+14 more Roswell Park Cancer Institute 10
Not applicableNot Yet RecruitingNCT07635485What this trial is testingVA Induction and Bridging Transplantation for Hypoplastic/Secondary AMLWho this might be right forHypoplastic Acute Myeloid LeukemiaSecondary AML (Adult) The First Affiliated Hospital of Soochow University 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07372885What this trial is testingGRanulocyte Augmented Cord Blood Transplantation for Poor Risk leukaEmiaWho this might be right forAcute Myeloid LeukemiaStem Cell TransplantationStem Cell Transplantation, Hematopoietic+2 more University of Manchester 50
Testing effectiveness (Phase 2)Study completedNCT03823352What this trial is testingEvaluate Efficacy and Safety/Tolerability Profiles of Antroquinonol in Acute Myeloid Leukemia (AML) Adult PatientsWho this might be right forLeukemia, Myeloid, Acute Golden Biotechnology Corporation 12
Large-scale testing (Phase 3)Study completedNCT00085709What this trial is testingS0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AMLWho this might be right forLeukemia SWOG Cancer Research Network 637
Early research (Phase 1)Study completedNCT01051063What this trial is testingEvaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction ChemotherapyWho this might be right forLeukaemia, Myelocytic, Acute GlaxoSmithKline 17
Large-scale testing (Phase 3)Enrolling By InvitationNCT07651163What this trial is testingComparing the Efficacy of LDA, LHAA, and LA Regimens in Young Adults With Intermediate- and High-Risk Acute Myeloid Leukemia Eligible for Intensive ChemotherapyWho this might be right forAcute Myeloid Leukemia (AML)Lisaftoclax First Affiliated Hospital of Zhejiang University 450